0001104659-22-119876.txt : 20221117 0001104659-22-119876.hdr.sgml : 20221117 20221117160146 ACCESSION NUMBER: 0001104659-22-119876 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221115 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TUCHMAN ALAN J CENTRAL INDEX KEY: 0001417631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40458 FILM NUMBER: 221398304 MAIL ADDRESS: STREET 1: 18 SYCAMORE ROAD CITY: MAHOPAC STATE: NY ZIP: 10541 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Synaptogenix, Inc. CENTRAL INDEX KEY: 0001571934 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461585656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 9732420005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC. DATE OF NAME CHANGE: 20130312 4 1 tm2230820-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-11-15 0 0001571934 Synaptogenix, Inc. SNPX 0001417631 TUCHMAN ALAN J C/O SYNAPTOGENIX, INC., 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 6.07 2022-11-15 4 A 0 112000 0.00 A 2032-11-15 Common Stock, par value $0.0001 per share 112000 112000 D These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer. /s/ Robert Weinstein, Attorney-in-fact 2022-11-17